These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 39226310)

  • 1. Energy landscapes of peptide-MHC binding.
    Collesano L; Łuksza M; Lässig M
    PLoS Comput Biol; 2024 Sep; 20(9):e1012380. PubMed ID: 39226310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes.
    Zhao W; Sher X
    PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of antigenic peptides by products of the major histocompatibility complex.
    Fairchild PJ
    J Pept Sci; 1998 May; 4(3):182-94. PubMed ID: 9643627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.
    Benichou G; Takizawa PA; Ho PT; Killion CC; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1990 Nov; 172(5):1341-6. PubMed ID: 1700053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Static energy analysis of MHC class I and class II peptide-binding affinity.
    Davies MN; Flower DR
    Methods Mol Biol; 2007; 409():309-20. PubMed ID: 18450011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of tripeptides in MHC binding peptides.
    Anishettt S; Pennathur G
    Protein Pept Lett; 2007; 14(6):552-6. PubMed ID: 17627595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides bound to major histocompatibility complex molecules.
    Maffei A; Harris PE
    Peptides; 1998; 19(1):179-98. PubMed ID: 9437752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules.
    Appella E; Padlan EA; Hunt DF
    EXS; 1995; 73():105-19. PubMed ID: 7579970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico prediction of peptide-MHC binding affinity using SVRMHC.
    Liu W; Wan J; Meng X; Flower DR; Li T
    Methods Mol Biol; 2007; 409():283-91. PubMed ID: 18450008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.
    Nielsen M; Lundegaard C; Worning P; Hvid CS; Lamberth K; Buus S; Brunak S; Lund O
    Bioinformatics; 2004 Jun; 20(9):1388-97. PubMed ID: 14962912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.
    Nielsen M; Lundegaard C; Lund O
    BMC Bioinformatics; 2007 Jul; 8():238. PubMed ID: 17608956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide binding by class I and class II MHC molecules.
    Batalia MA; Collins EJ
    Biopolymers; 1997; 43(4):281-302. PubMed ID: 9316393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biochemistry and cell biology of antigen processing and presentation.
    Germain RN; Margulies DH
    Annu Rev Immunol; 1993; 11():403-50. PubMed ID: 8476568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning reveals a non-canonical mode of peptide binding to MHC class II molecules.
    Andreatta M; Jurtz VI; Kaever T; Sette A; Peters B; Nielsen M
    Immunology; 2017 Oct; 152(2):255-264. PubMed ID: 28542831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide binding to MHC class I and II proteins: new avenues from new methods.
    Yaneva R; Schneeweiss C; Zacharias M; Springer S
    Mol Immunol; 2010 Jan; 47(4):649-57. PubMed ID: 19910050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide binding motifs for MHC class I and II molecules.
    Biddison WE; Martin R
    Curr Protoc Immunol; 2001 May; Appendix 1():Appendix 1I. PubMed ID: 18432645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms.
    Reche PA; Reinherz EL
    J Mol Biol; 2003 Aug; 331(3):623-41. PubMed ID: 12899833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.
    Bordner AJ
    PLoS One; 2010 Dec; 5(12):e14383. PubMed ID: 21187956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.